Gastro-intestinal system

K&M Inflammatory Bowel Disease (Adults) HCD Pathway

K&M PRGC PR 2022-25: Dual biological therapy for inflammatory bowel disease (IBD) in adults

K&M PRGC PR 2024-10: Dose escalation of subcutaneous infliximab for inflammatory bowel disease (IBD)

 K&M ICB Position Statement – GI Anti-spasmodics: Dicycloverine and Propantheline prescribing not supported

K&M ICB Position Statement - Proton Pump Inhibitor (PPI) Oral Suspension for Adults in Primary Care

K&M ICB Position Statement - Omeprazole Oral Suspension for Paediatrics in Primary Care

K&M Stoma Accessories Formulary

K&M Prescribing of Deodorant Sprays for Stoma Care Position Statement

K&M Prescribing of Adhesive Remover Sprays/Wipes for Stoma Care Position Statement